Company Filing History:
Years Active: 2016
Title: David Gerrish: Innovator in Pharmaceutical Compounds
Introduction
David Gerrish is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on serotonin receptor ligands. His research focuses on developing compounds that can be used as therapeutic agents for various medical conditions.
Latest Patents
David Gerrish holds 1 patent related to a series of benzazepine compounds. These compounds are designed to modulate the activity of serotonin receptors (5-HT), which is crucial for treating diseases such as addiction, anxiety, depression, and obesity. His patent outlines the pharmaceutical compositions containing these compounds and their potential therapeutic applications.
Career Highlights
Throughout his career, David has been associated with Abt Holding Company, where he has been able to apply his expertise in pharmaceutical innovation. His work has contributed to advancements in the treatment of various disorders, showcasing his commitment to improving healthcare through scientific research.
Collaborations
David Gerrish has collaborated with notable colleagues, including Mike Robarge and John Joseph Harrington. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.
Conclusion
David Gerrish's contributions to the field of pharmaceuticals through his innovative compounds and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.